Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,463,979
+$1,788,558 QoQ
Shares Held
197,413
-5.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#154
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. NVO ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,463,979 | 197,413 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,675,421 | 208,855 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,789,130 | 94,126 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,867,690 | 159,807 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,000,683 | 159,384 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,367,664 | 134,903 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,981,297 | 81,159 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,641,354 | 97,769 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,777,547 | 68,499 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,012,822 | 54,617 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,598,507 | 54,118 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,667,768 | 51,328 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,442,609 | 21,273 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $3,671,518 | 23,071 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $2,861,222 | 21,141 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,184,885 | 21,930 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,315,403 | 20,779 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,019,666 | 18,187 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,121,728 | 18,944 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,802,587 | 18,775 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,522,268 | 18,172 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,176,141 | 17,445 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,030,846 | 14,758 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $992,571 | 14,296 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,877,508 | 28,673 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,832,006 | 30,432 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||